Heba Abd-El-Azim

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Combination Therapy

Vascular Endothelial Growth Factor

Tyrosine Kinase

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kholoud A Elzanaty, Gamal Abd El Hay Omran, Ehab Kotb Elmahallawy, Ashraf Albrakati, Ayman A Saleh, Naief Dahran, Alaa Saud Alhegaili, Ahmad Salahuddin, Heba Abd-El-Azim, Ahmed Elsayed Noreldin, Tarek M Okda
Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice. Pharmaceutics 16 (7) (2024)
Kholoud A Elzanaty, Gamal Abd El Hay Omran, Ehab Kotb Elmahallawy, Ashraf Albrakati, Ayman A Saleh, Naief Dahran, Alaa Saud Alhegaili, Ahmad Salahuddin, Heba Abd-El-Azim, Ahmed Elsayed Noreldin, Tarek M Okda
Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice. Pharmaceutics 16 (7) (2024)
Kholoud A Elzanaty, Gamal Abd El Hay Omran, Ehab Kotb Elmahallawy, Ashraf Albrakati, Ayman A Saleh, Naief Dahran, Alaa Saud Alhegaili, Ahmad Salahuddin, Heba Abd-El-Azim, Ahmed Elsayed Noreldin, Tarek M Okda
Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice. Pharmaceutics 16 (7) (2024)